Furthermore, studies have validated that ACE polymorphisms can affect ACE2 expression, leading to the CF phenotype and pulmonary inflammation associated with the development of COVID-19 (Vitiello et al., 2023). This evidence concerns the gene ACE2 and cystic fibrosis.